Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Psyched Wellness (PSYC) has announced a manufacturing partnership with Vantage Hemp Co.
  • David Shisel, COO of Psyched Wellness sat down with Dave Jackson to discuss the partnership
  • The agreement includes extraction, commercial production and bottling of the products
  • Psyched Wellness will present a product derived from the Amanita Muscaria mushroom that is safe for human consumption using its proprietary extract, AME-1
  • Vantage specializes in medical, pharmaceutical, manufacturing and business operations
  • Psyched Wellness is a health supplements company dedicated to the distribution of mushroom-derived products
  • Psyched Wellness (PSYC) opened trading at C$0.125 per share

Psyched Wellness (PSYC) has announced a manufacturing partnership with Vantage Hemp Co.

David Shisel, COO of Psyched Wellness sat down with Dave Jackson to discuss the partnership.

Vantage Hemp Co. will act as the company’s contract manufacturing organization partner, facilitating the path to market for Psyched’s AME-1-derived consumer products.

The agreement includes extraction, commercial production and bottling of the products. The companies will work together to finalize the good manufacturing practices compliance process and final product formulation.

David Shisel, Chief Operating Officer of Psyched Wellness, commented on the partnership with Vantage.

“Psyched Wellness is very pleased to partner with Vantage, an established extract manufacturer that meets our high standards of pharmaceutical quality and shares our vision for the future. Together, we plan to produce and supply the highest quality products to global markets, starting with the United States before scaling distribution internationally. The AME-1-derived supplements that Psyched has been developing for the past two years are natural remedies that will improve the quality of life for many.

For the first time in modern history, Psyched Wellness will present a product derived from the Amanita Muscaria mushroom that is safe for human consumption using our proprietary extract, AME-1. Psyched and Vantage both believe in the success of AME-1 as an ingredient and are ensuring that we have the infrastructure and capabilities to scale production to high volumes without sacrificing quality.”

Vantage specializes in medical, pharmaceutical, manufacturing and business operations, creating the highest quality products with precision and scale. In addition, Vantage’s cleanroom for the production of finished products ensures the final products are manufactured in controlled environments that mitigate contamination.

Harvinder Johal, CRO of Vantage, added,

“Our partnership with Psyched Wellness ensures that this valuable therapy will be brought to market at an accelerated rate by leveraging Vantage’s science-based and data-driven ethos. We are eager to allow consumers access to this product for the improvement of their health and wellness. Applying our extraction standards to mushroom biomass ensures that the final product meets the same stringent quality standards that we apply to hemp extraction.”

Psyched Wellness is a health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods.

Psyched Wellness (PSYC) opened trading at C$0.125 per share.

More From The Market Herald

" @ the Bell: TSX plunges as oil drops

Canada’s main stock index closed out the week in the red on Friday in a broad decline.

" As the market falls, investors turn to tech stocks

Canadians received news from Statistics Canada this week that inflation dropped to 7.0 per cent in August.

" Lobe Sciences (CSE:LOBE) incorporates Australian subsidiary for psilocin trials

Lobe Sciences (LOBE) has incorporated its wholly-owned Australian subsidiary to facilitate three or more clinical trials.
The Market Herald Video

" Dundee Corporation (TSX:DC.A) closes privatization of Big River Gold

Dundee (DC.A) has closed its privatization of Big River Gold with Aura Minerals.